ESC Webinar: Implementation of Remote Monitoring in CIEDs in Clinical Practice WEBINAR REMOTE MONITORING ESC EVENT
JAPANESE PMDA APPROVAL FOR BIOFREEDOM™ ULTRA AND US FDA APPROVAL FOR BIOFREEDOM™ Biosensors International is pleased to announce both Japanese PMDA approval for BioFreedom™ Ultra on 31st March 2022 and also US FDA approval for BioFreedom™ on 14th April 2022.
BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN NEW SEMI-COMPLIANT BALLOON TRIAL “RISE SC STUDY". This ongoing trial will evaluate the performance of the new RISETM SC balloon which will complete the Biosensors International balloon portfolio.
The Effects of Air Pollution on Heart Health STORYHEALTH & WELLNESS CARDIOLOGY INSIGHTS POLLUTION ENVIRONMENT
Announcement of co-sponsored session during CTO Club 2022 CTO Club 2022 will be held a virtual meeting from June 17th and 18th, 2022.
BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PIVOTAL TRIAL OF NEW CORONARY MICROCATHETER - "BIOMICS". The BIOMICS study is a prospective, multi-center evaluation of the safety and effectiveness of the Biosensors Microcatheter in patients undergoing Percutaneous Coronary Intervention (PCI) for the treatment of chronic total occlusions (CTO).
Best Life հայ- ճապոնական բժշկական կենտրոն Best Life հայ- ճապոնական բժշկական կենտրոնում գործող վերջույթների պահպանման կենտրոնն արդեն գրանցել է իր առաջին հաջողությունը: